Showing results (121-130 of 128) with videos related to
Sort By:
Pageof 13
You have reached the last page of results.This site can display upto 128 results.
Infection and Immunity|March 26, 2003
Expression of multiple outer membrane protein sequence variants from a single genomic locus of Anaplasma phagocytophilumA F Barbet, P F M Meeus, M Bélanger, et al.Proceedings of the National Academy of Sciences of the United States of America|October 17, 2020
Histone H3.3 G34 mutations promote aberrant PRC2 activity and drive tumor progressionSiddhant U Jain, Sima Khazaei, Dylan M Marchione, et al.Molecular Cell|October 13, 2020
H3 K27M and EZHIP Impede H3K27-Methylation Spreading by Inhibiting Allosterically Stimulated PRC2Siddhant U Jain, Andrew Q Rashoff, Samuel D Krabbenhoft, et al.Science Translational Medicine|January 18, 2019
Tuberculosis following PD-1 blockade for cancer immunotherapyDaniel L Barber, Shunsuke Sakai, Ragini R Kudchadkar, et al.JAMA Oncology|June 3, 2019
Assessment of the Safety of Pembrolizumab in Patients With HIV and Advanced Cancer-A Phase 1 StudyThomas S Uldrick, Priscila H Gonçalves, Maher Abdul-Hay, et al.Science (New York, N.Y.)|May 14, 2016
Histone H3K36 mutations promote sarcomagenesis through altered histone methylation landscapeChao Lu, Siddhant U Jain, Dominik Hoelper, et al.Nature Communications|February 3, 2026
Can ferric-oxyl excited states explain elongated iron-oxygen bonds in heme peroxidase catalytic intermediates?Lewis J Williams, Jos J A G Kamps, Adrian M V Brânzanic, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 7, 2019
Durable Tumor Regression and Overall Survival in Patients With Advanced Merkel Cell Carcinoma Receiving Pembrolizumab as First-Line TherapyPaul Nghiem, Shailender Bhatia, Evan J Lipson, et al.Pageof 13